全文获取类型
收费全文 | 257篇 |
免费 | 41篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 4篇 |
妇产科学 | 3篇 |
基础医学 | 27篇 |
临床医学 | 11篇 |
内科学 | 155篇 |
神经病学 | 7篇 |
特种医学 | 2篇 |
外科学 | 12篇 |
综合类 | 6篇 |
预防医学 | 6篇 |
药学 | 53篇 |
肿瘤学 | 11篇 |
出版年
2023年 | 3篇 |
2019年 | 4篇 |
2016年 | 2篇 |
2015年 | 3篇 |
2013年 | 2篇 |
2012年 | 10篇 |
2011年 | 4篇 |
2009年 | 4篇 |
2008年 | 5篇 |
2007年 | 9篇 |
2006年 | 10篇 |
2005年 | 7篇 |
2004年 | 10篇 |
2003年 | 6篇 |
2002年 | 7篇 |
2001年 | 11篇 |
2000年 | 9篇 |
1999年 | 6篇 |
1998年 | 5篇 |
1997年 | 6篇 |
1996年 | 2篇 |
1994年 | 2篇 |
1992年 | 19篇 |
1991年 | 6篇 |
1990年 | 6篇 |
1989年 | 6篇 |
1988年 | 16篇 |
1987年 | 7篇 |
1986年 | 2篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1972年 | 10篇 |
1971年 | 11篇 |
1970年 | 4篇 |
1969年 | 7篇 |
1968年 | 5篇 |
1967年 | 2篇 |
1965年 | 3篇 |
1964年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有298条查询结果,搜索用时 15 毫秒
1.
Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice 总被引:2,自引:0,他引:2
Anne Bourson Véronique Kapps Catherine Zwingelstein Alain Rudler Frank G. Boess A. J. Sleight 《Naunyn-Schmiedeberg's archives of pharmacology》1997,356(6):820-826
Audiogenic seizures can be induced in DBA/2J mice following intense auditory stimulation. A number of neurotransmitters, including
5-hydroxytryptamine (5-HT), are believed to be involved in mediating this effect since it has been shown previously that depletion
of 5-HT or blockade of 5-HT receptors protects DBA/2J mice from these audiogenic seizures. The present study was undertaken
to determine whether antagonism of the newly identified 5-HT7 receptor may protect DBA/2J mice from audiogenic seizures by attempting to correlate in vivo potency of compounds with their
affinity at the 5-HT7 receptor. All compounds used in the correlation were shown to be antagonists at the 5-HT7 receptor and a statistically significant correlation was observed between 5-HT7 affinity and doses for half-maximal response (ED50) for protection of DBA/2J mice from sound-induced seizures (r = 0.80; P < 0.05). No significant correlation was observed between in vivo activity and affinity at either 5-HT1A, 5-HT2A or 5-HT2C receptors. It is also unlikely that interactions between the 5-ht5 receptor will protect DBA/2J mice from audiogenic seizures since metergoline and mesulergine which are both active in this
in vivo model have no affinity for the 5-ht5 receptor. There are similarities between the pharmacology of the 5-HT7 receptor and that of the 5-HT1A receptor, however the correlation between the in vivo potency in DBA/2J mice and 5-HT1A affinity was not significant. Furthermore, the 5-HT1A receptor antagonist WAY 100135 did not protect DBA/2J mice from audiogenic seizures at doses that antagonise 5-HT1A receptor-mediated effects in mice. These data suggest that antagonism of 5-HT7 receptors may protect against audiogenic seizures in DBA/2J mice although a definitive conclusion must await studies with
selective 5-HT7 antagonists.
Received: 20 March 1997 / Accepted: 10 August 1997 相似文献
2.
Black HR Elliott WJ Neaton JD Grandits G Grambsch P Grimm RH Hansson L Lacoucière Y Muller J Sleight P Weber MA White WB Williams G Wittes J Zanchetti A Fakouhi TD Anders RJ 《Hypertension》2001,37(1):12-18
-Blood pressure (BP) control rates around the world are suboptimal. Part 2 of the National Health and Nutrition Educational Survey (NHANES) III indicates that only 27.4% of hypertensive Americans aged 18 to 74 years have a BP of <140/90 mm Hg. We wanted to assess BP control during the first 2 years and to describe the baseline characteristics of patients enrolled in the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Study, an international clinical trial that compares outcomes in hypertensive patients randomized to initial treatment with either controlled-onset extended-release verapamil or the investigator's choice of atenolol or hydrochlorothiazide. At randomization, BP was <140/90 mm Hg in only 20.3% of the 16 602 subjects (average+/-SD age 65.6+/-7.4 years; 56% women, 84% white/7% black/7% Hispanic). The average BP at enrollment was 148/85 mm Hg for patients taking BP medications (n=13 879) and 161/94 mm Hg for previously untreated patients (n=2723). After medication titration, with a transtelephonic computer that recommended an increase in the dose or number of antihypertensive agents whenever the BP was 140/90 mm Hg, 84.8% of the subjects attained the goal BP. During 2 years of treatment, BP control was maintained in 67% to 69% of the subjects (69% to 71% for systolic BP of <140 mm Hg and 90% for diastolic BP of <90 mm Hg). These data suggest that the control of systolic BP is more difficult than the control of diastolic BP. The US national goal of having 50% of hypertensives with a BP of <140/90 mm Hg may be achievable if a forced titration strategy is used. Interested investigators, free care and medications, and well-educated subjects may make the attainment of such a goal easier in the CONVINCE study than in the general population. 相似文献
3.
Jagmeet P. Singh Jim Johnston Peter Sleight Maria F. Marinho Sara Kulangara Barbara Casadei George Hart 《Annals of noninvasive electrocardiology》1997,2(3):242-253
Background: The incidence of sudden cardiac death is maximal in the morning hours. Although ventricular arrhythmias have been implicated as a potential mechanism, and several neurohumoral factors affecting myocardial excitability have been shown to be raised in the early morning hours, it is not known if there is any circadian variation in the dynamics of ventricular repolarization when studied on a beat-to-beat basis. The objective of this study was to examine the range, diurnal variations, and circadian distribution of the variability of the QT interval in healthy subjects. Method: We developed and validated a new method for continuous measurement of QT intervals from 24-hour Holter recordings. The QT intervals measured semi-automatically were corrected by a linear regression formula derived independently for each patient from his own QT and RR values in 32 healthy males (20 ± 0.4 years). QT variability was assessed by the mean standard deviation of the average of consecutive uncorrected QT intervals (SDA-QT Index) and corrected QT intervals (SDA-QTc index) over 5-minute segments. The rate-dependent changes of the QT interval were studied as a function of the slope of the regression line between the QT and RR values. Results: The average QTc range was mean (SD) 79 (± 28) ms; the average maximal QTc interval was 481 (± 24) ms. The 95% upper confidence limit for the mean 24-hour QTc interval was 443 ms. The RR, QT, and QTc intervals were longer, while the SDA-QT and SDA-QTc indices were shorter during sleep. Hourly averages of the SDA-QT and SDA- QTc index revealed a sudden increase in QT variability in the first hour of waking (P < 0.0001 and P = 0.006). Conclusion: The dynamic behavior of the QT interval shows significant diurnal variations. The maximal QTc interval over 24 hours is longer than previously assumed. The period shortly following awakening is characterized by a peak in the variability of the QT interval. These changes may be indicative of autonomic instability during the early waking hours and correspond with the peak incidence of sudden arrhythmic death. 相似文献
4.
5.
受1例胸部钝性创伤后出现心绞痛患者(无冠心病危险因素,为单支冠状动脉病变)启发,作者检索了Medline,共发现了77例胸部钝性创伤后出现急性心肌梗死的患者,但仅有1例报道有心绞痛。随后重点研究了年龄及性别分布、创伤类型、冠状动脉造影结果以及创伤与造影的时间间隔。与一般急性心肌梗死不同,胸部钝性创伤后急性心肌梗死患者年龄分布不典型:82%患者低于45岁,超过60岁者只占2.5%。最常见的创伤是公路交通事故,冠状动脉前降支最常受累。造影显示12例患者血管完全正常,可能与血管痉挛或再通有关;31例显示冠状动脉阻塞但无粥样病变,强烈提示创伤与冠状动脉阻塞存在因果关系。故对钝性创伤后胸痛患者应该考虑到急性心肌梗死的可能。由于创伤性心肌梗死的发病机制可能为内膜撕裂或夹层形成,所以溶栓治疗可能恶化病情,应首先考虑急诊PCI。具有医疗法律意义的是,轻微的损伤可能导致远期狭窄,但我们怀疑此后果在很大程度上被忽略了。 相似文献
6.
In mice, only makes are susceptible to chloroform (CHCl3) nephrotoxicity and the susceptibility appears to be related to renal mixed function oxidase activity. There were sex-related differences of renal cytochrome P-450 and b5 concentrations and of ethoxycoumarin O-deethylase activity in mouse kidneys; in all cases activity was higher in males. Castration of male mice eliminated susceptibility to ChCl3 nephrotoxicity and reduced renal mixed function oxidases to concentrations observed in female mice. Treatment of male and female mice with testosterone increased the susceptibility to ChCl3 nephrotoxicity and increased renal mixed function oxidases to similar activities in both sexes. Previous data have suggested that CHCl3 is metabolized in situ by the kidney, possibly by a mechanism similar to that occurring in the liver. The data from this investigation are consistent with the concept that CHCl3 is metabolized by a cytochrome P-450-dependent mechanism in the kidney. 相似文献
7.
Sleight P 《American heart journal》2004,148(2):188-189
8.
We reviewed the drug treatment of hypertension in the light of recent trials. beta-Blockers and diuretics clearly reduce mortality, strokes, and coronary heart disease (CHD) in hypertension. Recent trials assessed whether newer agents that block the renin-angiotensin-aldosterone system, or calcium blockers, offer any additional advantage, or have benefits in high-risk individuals with conventionally 'normal' blood pressure. The recent ALLHAT study claimed no differences in CHD or mortality when chlorthalidone, amlodipine, and lisinopril were compared. However, the decrease in blood pressure was not the same with the three agents, and a substantial proportion of patients enrolled did not have clinical disease. In contrast, the LIFE study (comparing losartan and a beta-blocker) and the ANBP-2 study [comparing angiotensin-converting enzyme (ACE) inhibition and a diuretic] reduced blood pressure similarly, yet demonstrated benefits in favour of angiotensin II type 1 receptor blockers (ARBs) and ACE inhibitors. Other trials indicated similar advantages of ACE inhibitors or ARBs in patients with diabetic nephropathy. Among high-risk patients with initial blood pressure in the 'normal' range, ACE inhibitors significantly reduce clinical events (mortality, strokes, and myocardial infarction), despite modest decreases in blood pressure, suggesting that additional mechanisms are responsible. Recent results of the Prospective Studies Collaboration show lower risk, even in the normal blood pressure range; high-risk patients will benefit further from ACE inhibitors and ARBs (and beta-blockers after myocardial infarction). Data for other blood pressure decreasing agents are unavailable in such populations. We conclude that blood pressure decreasing per se is of clinical benefit, but drugs that block the renin-angiotensin system offer additional advantages. Drug choice is best determined by the patient's clinical condition. 相似文献
9.
10.
George Bakris Michael Böhm Gilles Dagenais Hans-Christoph Diener Toshiro Fujita Philip Gorelick Sverre Erik Kjeldsen Markku Laakso Giuseppe Mancia Bertram Pitt Arya Sharma Peter Sleight Koon Teo Thomas Unger Michael Weber Bryan Williams Faiez Zannad 《Clinical research in cardiology》2008,97(10):713-725
Patients with cardiovascular risk factors are largely undertreated, for many reasons. Vulnerable individuals may not be aware
of the risks they are facing or an individual’s risk of cardiovascular disease may be underestimated, particularly among those
at high risk. Furthermore, in individuals identified as being at high total cardiovascular risk, the full spectrum of therapeutic
options may not be implemented or patients may not adhere to the treatment prescribed. We address these critical issues by
summarizing the existing guidelines: our ultimate goal is to encourage the optimal management of individuals at high total
cardiovascular risk according to evidence-based medicine, with the expectation that this will improve outcomes. 相似文献